Dopaminergic but not noradrenergic mediation of hyperactivity and performance deficits in the developing rat pup
- PMID: 6420833
- DOI: 10.1007/BF00426384
Dopaminergic but not noradrenergic mediation of hyperactivity and performance deficits in the developing rat pup
Abstract
The relative contribution of dopamine (DA) and norepinephrine (NE) in behavioral arousal was examined in developing rat pups using intracisternal 6-hydroxydopamine (6-OHDA) either alone or following pretreatment with desmethylimipramine (DMI). Such treatments were designed to examine the effects of preferential reduction of DA (DA depletion), NE (NE depletion), or both catecholamines (CA depletion) in the development of motor activity and escape performance. General motor activity increased with age and, over all ages, DA-depleted pups tended to exhibit greater activity. This was most apparent at 15 days of age, where DA-depleted pups were significantly more active than controls, NE-depleted, or CA-depleted pups. DA-depleted pups failed to exhibit the steep decline in activity over time (habituation of activity) demonstrated by the control and NE-depleted pups, while pups depleted of both CA fell into an intermediate position in habituation. Escape latency in a T-maze at 20 days and shuttle box at 26 days of age indicated comparable performance to controls for NE-depleted pups, while those animals in DA-depleted and CA-depleted groups appeared unable to perform the task. Brain CA concentrations (determined by a radioenzymatic assay) indicated preferential reduction of DA in the DA-depleted group to concentrations 25% of controls, reduction of NE to 62% of controls in the NE-depleted group, and reductions of DA to 42% and NE to 60% in the CA-depleted group. These results suggest that preferential reduction of brain DA in the developing rat pup increases motor activity and impairs habituation of activity during the stage of behavioral arousal in week 3 of postnatal life.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Differential effects of selective dopamine, norepinephrine or catecholamine depletion on activity and learning in the developing rat.Pharmacol Biochem Behav. 1983 Nov;19(5):743-9. doi: 10.1016/0091-3057(83)90073-4. Pharmacol Biochem Behav. 1983. PMID: 6647508
-
Effects of bromocriptine in developing rat pups after 6-hydroxydopamine.Pharmacol Biochem Behav. 1981 Sep;15(3):443-8. doi: 10.1016/0091-3057(81)90275-6. Pharmacol Biochem Behav. 1981. PMID: 6794039
-
Effects of apomorphine on escape performance and activity in developing rat pups treated with 6-hydroxydopamine (6-OHDA).Pharmacol Biochem Behav. 1980 Sep;13(3):371-7. doi: 10.1016/0091-3057(80)90241-5. Pharmacol Biochem Behav. 1980. PMID: 7191569
-
Effect of spinal norepinephrine depletion on descending inhibition of the tail flick reflex from the locus coeruleus and lateral reticular nucleus in the rat.Brain Res. 1987 Jan 1;400(1):40-52. doi: 10.1016/0006-8993(87)90651-2. Brain Res. 1987. PMID: 3101973 Review.
-
Modulation of eating by central catecholamine systems.Curr Drug Targets. 2005 Mar;6(2):191-9. doi: 10.2174/1389450053174532. Curr Drug Targets. 2005. PMID: 15777189 Review.
Cited by
-
Effect of neonatal nomifensine exposure on adult behavior and brain monoamines in rats.J Neural Transm. 1987;70(1-2):99-116. doi: 10.1007/BF01252512. J Neural Transm. 1987. PMID: 3668522
-
Transgenic mice bearing a human mutant thyroid hormone beta 1 receptor manifest thyroid function anomalies, weight reduction, and hyperactivity.Mol Med. 1997 May;3(5):303-14. Mol Med. 1997. PMID: 9205946 Free PMC article.
-
Buspirone versus methylphenidate in the treatment of attention deficit hyperactivity disorder: a double-blind and randomized trial.Child Psychiatry Hum Dev. 2010 Dec;41(6):641-8. doi: 10.1007/s10578-010-0193-2. Child Psychiatry Hum Dev. 2010. PMID: 20517641 Clinical Trial.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources